nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Vismodegib—skin cancer	0.285	0.34	CbGbCtD
Nitrofurantoin—ABCG2—Vemurafenib—skin cancer	0.225	0.269	CbGbCtD
Nitrofurantoin—ABCG2—Dactinomycin—skin cancer	0.15	0.179	CbGbCtD
Nitrofurantoin—ABCG2—Fluorouracil—skin cancer	0.101	0.121	CbGbCtD
Nitrofurantoin—ABCG2—Docetaxel—skin cancer	0.0772	0.0922	CbGbCtD
Nitrofurantoin—Eruption—Dactinomycin—skin cancer	0.00196	0.012	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Bleomycin—skin cancer	0.00182	0.0112	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Temozolomide—skin cancer	0.00154	0.00945	CcSEcCtD
Nitrofurantoin—Alopecia—Vismodegib—skin cancer	0.00153	0.0094	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Docetaxel—skin cancer	0.0015	0.0092	CcSEcCtD
Nitrofurantoin—Nystagmus—Fluorouracil—skin cancer	0.0014	0.00862	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Imiquimod—skin cancer	0.0014	0.00858	CcSEcCtD
Nitrofurantoin—Eosinophilia—Vemurafenib—skin cancer	0.00132	0.00813	CcSEcCtD
Nitrofurantoin—Myalgia—Vismodegib—skin cancer	0.00128	0.00788	CcSEcCtD
Nitrofurantoin—Tingling sensation—Fluorouracil—skin cancer	0.00125	0.00766	CcSEcCtD
Nitrofurantoin—Numbness—Fluorouracil—skin cancer	0.00121	0.00743	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00118	0.00726	CcSEcCtD
Nitrofurantoin—Eruption—Docetaxel—skin cancer	0.00118	0.00723	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Vemurafenib—skin cancer	0.00117	0.00717	CcSEcCtD
Nitrofurantoin—Sensory loss—Fluorouracil—skin cancer	0.00116	0.00711	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Dactinomycin—skin cancer	0.00113	0.00694	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00112	0.00688	CcSEcCtD
Nitrofurantoin—Dyspepsia—Vismodegib—skin cancer	0.00108	0.00665	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vismodegib—skin cancer	0.00107	0.00657	CcSEcCtD
Nitrofurantoin—Liver disorder—Docetaxel—skin cancer	0.00106	0.00652	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vismodegib—skin cancer	0.00106	0.00652	CcSEcCtD
Nitrofurantoin—Haemoglobin decreased—Docetaxel—skin cancer	0.00105	0.00646	CcSEcCtD
Nitrofurantoin—Constipation—Vismodegib—skin cancer	0.00105	0.00646	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Docetaxel—skin cancer	0.00102	0.00628	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Temozolomide—skin cancer	0.00102	0.00628	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Vemurafenib—skin cancer	0.00101	0.00621	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00101	0.00619	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Vismodegib—skin cancer	0.00101	0.00618	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Imiquimod—skin cancer	0.000995	0.00612	CcSEcCtD
Nitrofurantoin—Abdominal pain—Vismodegib—skin cancer	0.000972	0.00597	CcSEcCtD
Nitrofurantoin—Chills—Vemurafenib—skin cancer	0.000959	0.00589	CcSEcCtD
Nitrofurantoin—Pleural effusion—Docetaxel—skin cancer	0.000945	0.00581	CcSEcCtD
Nitrofurantoin—Alopecia—Vemurafenib—skin cancer	0.000945	0.00581	CcSEcCtD
Nitrofurantoin—Asthenia—Vismodegib—skin cancer	0.000882	0.00542	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Imiquimod—skin cancer	0.000862	0.0053	CcSEcCtD
Nitrofurantoin—Euphoric mood—Fluorouracil—skin cancer	0.000861	0.00529	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vismodegib—skin cancer	0.000841	0.00517	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Temozolomide—skin cancer	0.000837	0.00514	CcSEcCtD
Nitrofurantoin—Chills—Imiquimod—skin cancer	0.000818	0.00503	CcSEcCtD
Nitrofurantoin—Cough—Vemurafenib—skin cancer	0.000812	0.00499	CcSEcCtD
Nitrofurantoin—Alopecia—Imiquimod—skin cancer	0.000806	0.00495	CcSEcCtD
Nitrofurantoin—Myalgia—Vemurafenib—skin cancer	0.000792	0.00487	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.000786	0.00483	CcSEcCtD
Nitrofurantoin—Vomiting—Vismodegib—skin cancer	0.000782	0.0048	CcSEcCtD
Nitrofurantoin—Rash—Vismodegib—skin cancer	0.000775	0.00476	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Vemurafenib—skin cancer	0.000759	0.00467	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Imiquimod—skin cancer	0.000736	0.00453	CcSEcCtD
Nitrofurantoin—Nausea—Vismodegib—skin cancer	0.00073	0.00449	CcSEcCtD
Nitrofurantoin—Malaise—Imiquimod—skin cancer	0.000716	0.0044	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.000711	0.00437	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Temozolomide—skin cancer	0.000696	0.00428	CcSEcCtD
Nitrofurantoin—Cough—Imiquimod—skin cancer	0.000692	0.00426	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000692	0.00425	CcSEcCtD
Nitrofurantoin—Myalgia—Imiquimod—skin cancer	0.000676	0.00415	CcSEcCtD
Nitrofurantoin—Chest pain—Imiquimod—skin cancer	0.000676	0.00415	CcSEcCtD
Nitrofurantoin—Discomfort—Imiquimod—skin cancer	0.000668	0.0041	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000667	0.0041	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vemurafenib—skin cancer	0.00066	0.00406	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000656	0.00403	CcSEcCtD
Nitrofurantoin—Constipation—Vemurafenib—skin cancer	0.000649	0.00399	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Bleomycin—skin cancer	0.000644	0.00396	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Dactinomycin—skin cancer	0.000628	0.00386	CcSEcCtD
Nitrofurantoin—Eosinophilia—Fluorouracil—skin cancer	0.000623	0.00383	CcSEcCtD
Nitrofurantoin—Anorexia—Imiquimod—skin cancer	0.000617	0.00379	CcSEcCtD
Nitrofurantoin—Hepatitis—Dactinomycin—skin cancer	0.000604	0.00371	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000603	0.00371	CcSEcCtD
Nitrofurantoin—Body temperature increased—Vemurafenib—skin cancer	0.0006	0.00369	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Temozolomide—skin cancer	0.000597	0.00367	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00059	0.00363	CcSEcCtD
Nitrofurantoin—Paraesthesia—Imiquimod—skin cancer	0.000582	0.00357	CcSEcCtD
Nitrofurantoin—Chills—Bleomycin—skin cancer	0.000581	0.00357	CcSEcCtD
Nitrofurantoin—Dyspnoea—Imiquimod—skin cancer	0.000577	0.00355	CcSEcCtD
Nitrofurantoin—Somnolence—Imiquimod—skin cancer	0.000576	0.00354	CcSEcCtD
Nitrofurantoin—Alopecia—Bleomycin—skin cancer	0.000572	0.00352	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Dactinomycin—skin cancer	0.000571	0.00351	CcSEcCtD
Nitrofurantoin—Dyspepsia—Imiquimod—skin cancer	0.00057	0.0035	CcSEcCtD
Nitrofurantoin—Decreased appetite—Imiquimod—skin cancer	0.000563	0.00346	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Vemurafenib—skin cancer	0.00056	0.00344	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000559	0.00344	CcSEcCtD
Nitrofurantoin—Renal impairment—Docetaxel—skin cancer	0.000552	0.00339	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Fluorouracil—skin cancer	0.00055	0.00338	CcSEcCtD
Nitrofurantoin—Hepatitis—Temozolomide—skin cancer	0.000546	0.00336	CcSEcCtD
Nitrofurantoin—Asthenia—Vemurafenib—skin cancer	0.000545	0.00335	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Temozolomide—skin cancer	0.000544	0.00334	CcSEcCtD
Nitrofurantoin—Chills—Dactinomycin—skin cancer	0.000542	0.00333	CcSEcCtD
Nitrofurantoin—Alopecia—Dactinomycin—skin cancer	0.000534	0.00328	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Imiquimod—skin cancer	0.000534	0.00328	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Imiquimod—skin cancer	0.00053	0.00325	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Fluorouracil—skin cancer	0.000523	0.00322	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Bleomycin—skin cancer	0.000523	0.00321	CcSEcCtD
Nitrofurantoin—Anaemia—Bleomycin—skin cancer	0.000521	0.0032	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vemurafenib—skin cancer	0.00052	0.00319	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Temozolomide—skin cancer	0.000517	0.00317	CcSEcCtD
Nitrofurantoin—Abdominal pain—Imiquimod—skin cancer	0.000512	0.00315	CcSEcCtD
Nitrofurantoin—Body temperature increased—Imiquimod—skin cancer	0.000512	0.00315	CcSEcCtD
Nitrofurantoin—Malaise—Bleomycin—skin cancer	0.000508	0.00312	CcSEcCtD
Nitrofurantoin—Leukopenia—Bleomycin—skin cancer	0.000505	0.0031	CcSEcCtD
Nitrofurantoin—Dizziness—Vemurafenib—skin cancer	0.000502	0.00309	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Fluorouracil—skin cancer	0.000501	0.00308	CcSEcCtD
Nitrofurantoin—Cough—Bleomycin—skin cancer	0.000492	0.00302	CcSEcCtD
Nitrofurantoin—Chills—Temozolomide—skin cancer	0.00049	0.00301	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Dactinomycin—skin cancer	0.000488	0.003	CcSEcCtD
Nitrofurantoin—Anaemia—Dactinomycin—skin cancer	0.000486	0.00299	CcSEcCtD
Nitrofurantoin—Vomiting—Vemurafenib—skin cancer	0.000483	0.00297	CcSEcCtD
Nitrofurantoin—Alopecia—Temozolomide—skin cancer	0.000483	0.00297	CcSEcCtD
Nitrofurantoin—Chest pain—Bleomycin—skin cancer	0.00048	0.00295	CcSEcCtD
Nitrofurantoin—Myalgia—Bleomycin—skin cancer	0.00048	0.00295	CcSEcCtD
Nitrofurantoin—Rash—Vemurafenib—skin cancer	0.000479	0.00294	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Imiquimod—skin cancer	0.000477	0.00293	CcSEcCtD
Nitrofurantoin—Headache—Vemurafenib—skin cancer	0.000476	0.00292	CcSEcCtD
Nitrofurantoin—Discomfort—Bleomycin—skin cancer	0.000474	0.00291	CcSEcCtD
Nitrofurantoin—Malaise—Dactinomycin—skin cancer	0.000474	0.00291	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000473	0.00291	CcSEcCtD
Nitrofurantoin—Leukopenia—Dactinomycin—skin cancer	0.000471	0.00289	CcSEcCtD
Nitrofurantoin—Asthenia—Imiquimod—skin cancer	0.000465	0.00286	CcSEcCtD
Nitrofurantoin—Confusional state—Bleomycin—skin cancer	0.000464	0.00285	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000463	0.00285	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Bleomycin—skin cancer	0.00046	0.00283	CcSEcCtD
Nitrofurantoin—Nausea—Vemurafenib—skin cancer	0.000451	0.00277	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Bleomycin—skin cancer	0.00045	0.00277	CcSEcCtD
Nitrofurantoin—Myalgia—Dactinomycin—skin cancer	0.000448	0.00275	CcSEcCtD
Nitrofurantoin—Alopecia—Fluorouracil—skin cancer	0.000445	0.00273	CcSEcCtD
Nitrofurantoin—Diarrhoea—Imiquimod—skin cancer	0.000443	0.00272	CcSEcCtD
Nitrofurantoin—Discomfort—Dactinomycin—skin cancer	0.000442	0.00272	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Temozolomide—skin cancer	0.000441	0.00271	CcSEcCtD
Nitrofurantoin—Anaemia—Temozolomide—skin cancer	0.00044	0.0027	CcSEcCtD
Nitrofurantoin—Anorexia—Bleomycin—skin cancer	0.000439	0.0027	CcSEcCtD
Nitrofurantoin—Malaise—Temozolomide—skin cancer	0.000429	0.00264	CcSEcCtD
Nitrofurantoin—Dizziness—Imiquimod—skin cancer	0.000428	0.00263	CcSEcCtD
Nitrofurantoin—Vertigo—Temozolomide—skin cancer	0.000427	0.00263	CcSEcCtD
Nitrofurantoin—Leukopenia—Temozolomide—skin cancer	0.000426	0.00262	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Dactinomycin—skin cancer	0.00042	0.00258	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000419	0.00258	CcSEcCtD
Nitrofurantoin—Cough—Temozolomide—skin cancer	0.000415	0.00255	CcSEcCtD
Nitrofurantoin—Paraesthesia—Bleomycin—skin cancer	0.000413	0.00254	CcSEcCtD
Nitrofurantoin—Vomiting—Imiquimod—skin cancer	0.000412	0.00253	CcSEcCtD
Nitrofurantoin—Dyspnoea—Bleomycin—skin cancer	0.00041	0.00252	CcSEcCtD
Nitrofurantoin—Anorexia—Dactinomycin—skin cancer	0.000409	0.00251	CcSEcCtD
Nitrofurantoin—Rash—Imiquimod—skin cancer	0.000408	0.00251	CcSEcCtD
Nitrofurantoin—Headache—Imiquimod—skin cancer	0.000406	0.00249	CcSEcCtD
Nitrofurantoin—Anaemia—Fluorouracil—skin cancer	0.000405	0.00249	CcSEcCtD
Nitrofurantoin—Myalgia—Temozolomide—skin cancer	0.000405	0.00249	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000401	0.00247	CcSEcCtD
Nitrofurantoin—Discomfort—Temozolomide—skin cancer	0.0004	0.00246	CcSEcCtD
Nitrofurantoin—Decreased appetite—Bleomycin—skin cancer	0.0004	0.00246	CcSEcCtD
Nitrofurantoin—Renal failure—Docetaxel—skin cancer	0.000398	0.00244	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Docetaxel—skin cancer	0.000397	0.00244	CcSEcCtD
Nitrofurantoin—Leukopenia—Fluorouracil—skin cancer	0.000392	0.00241	CcSEcCtD
Nitrofurantoin—Confusional state—Temozolomide—skin cancer	0.000391	0.00241	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000391	0.0024	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Temozolomide—skin cancer	0.000388	0.00239	CcSEcCtD
Nitrofurantoin—Nausea—Imiquimod—skin cancer	0.000385	0.00236	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Temozolomide—skin cancer	0.00038	0.00234	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Bleomycin—skin cancer	0.000379	0.00233	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Docetaxel—skin cancer	0.000378	0.00232	CcSEcCtD
Nitrofurantoin—Myalgia—Fluorouracil—skin cancer	0.000373	0.00229	CcSEcCtD
Nitrofurantoin—Chest pain—Fluorouracil—skin cancer	0.000373	0.00229	CcSEcCtD
Nitrofurantoin—Decreased appetite—Dactinomycin—skin cancer	0.000373	0.00229	CcSEcCtD
Nitrofurantoin—Anorexia—Temozolomide—skin cancer	0.00037	0.00227	CcSEcCtD
Nitrofurantoin—Discomfort—Fluorouracil—skin cancer	0.000369	0.00227	CcSEcCtD
Nitrofurantoin—Body temperature increased—Bleomycin—skin cancer	0.000364	0.00224	CcSEcCtD
Nitrofurantoin—Hepatitis—Docetaxel—skin cancer	0.000363	0.00223	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Docetaxel—skin cancer	0.000361	0.00222	CcSEcCtD
Nitrofurantoin—Confusional state—Fluorouracil—skin cancer	0.000361	0.00222	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Fluorouracil—skin cancer	0.000358	0.0022	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Dactinomycin—skin cancer	0.000354	0.00217	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000354	0.00217	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000351	0.00216	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Fluorouracil—skin cancer	0.00035	0.00215	CcSEcCtD
Nitrofurantoin—Paraesthesia—Temozolomide—skin cancer	0.000349	0.00214	CcSEcCtD
Nitrofurantoin—Dyspnoea—Temozolomide—skin cancer	0.000346	0.00213	CcSEcCtD
Nitrofurantoin—Somnolence—Temozolomide—skin cancer	0.000345	0.00212	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Docetaxel—skin cancer	0.000343	0.00211	CcSEcCtD
Nitrofurantoin—Dyspepsia—Temozolomide—skin cancer	0.000342	0.0021	CcSEcCtD
Nitrofurantoin—Anorexia—Fluorouracil—skin cancer	0.000341	0.00209	CcSEcCtD
Nitrofurantoin—Abdominal pain—Dactinomycin—skin cancer	0.000339	0.00208	CcSEcCtD
Nitrofurantoin—Body temperature increased—Dactinomycin—skin cancer	0.000339	0.00208	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Bleomycin—skin cancer	0.000339	0.00208	CcSEcCtD
Nitrofurantoin—Decreased appetite—Temozolomide—skin cancer	0.000337	0.00207	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000335	0.00206	CcSEcCtD
Nitrofurantoin—Constipation—Temozolomide—skin cancer	0.000332	0.00204	CcSEcCtD
Nitrofurantoin—Asthenia—Bleomycin—skin cancer	0.00033	0.00203	CcSEcCtD
Nitrofurantoin—Chills—Docetaxel—skin cancer	0.000326	0.002	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000326	0.002	CcSEcCtD
Nitrofurantoin—Paraesthesia—Fluorouracil—skin cancer	0.000321	0.00197	CcSEcCtD
Nitrofurantoin—Alopecia—Docetaxel—skin cancer	0.000321	0.00197	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Temozolomide—skin cancer	0.00032	0.00197	CcSEcCtD
Nitrofurantoin—Dyspnoea—Fluorouracil—skin cancer	0.000319	0.00196	CcSEcCtD
Nitrofurantoin—Somnolence—Fluorouracil—skin cancer	0.000318	0.00195	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Temozolomide—skin cancer	0.000317	0.00195	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Dactinomycin—skin cancer	0.000316	0.00194	CcSEcCtD
Nitrofurantoin—Dyspepsia—Fluorouracil—skin cancer	0.000315	0.00193	CcSEcCtD
Nitrofurantoin—Decreased appetite—Fluorouracil—skin cancer	0.000311	0.00191	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000309	0.0019	CcSEcCtD
Nitrofurantoin—Asthenia—Dactinomycin—skin cancer	0.000308	0.00189	CcSEcCtD
Nitrofurantoin—Body temperature increased—Temozolomide—skin cancer	0.000307	0.00189	CcSEcCtD
Nitrofurantoin—Abdominal pain—Temozolomide—skin cancer	0.000307	0.00189	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Fluorouracil—skin cancer	0.000295	0.00181	CcSEcCtD
Nitrofurantoin—Diarrhoea—Dactinomycin—skin cancer	0.000294	0.0018	CcSEcCtD
Nitrofurantoin—Vomiting—Bleomycin—skin cancer	0.000293	0.0018	CcSEcCtD
Nitrofurantoin—Anaemia—Docetaxel—skin cancer	0.000292	0.0018	CcSEcCtD
Nitrofurantoin—Rash—Bleomycin—skin cancer	0.00029	0.00178	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Temozolomide—skin cancer	0.000286	0.00176	CcSEcCtD
Nitrofurantoin—Leukopenia—Docetaxel—skin cancer	0.000283	0.00174	CcSEcCtD
Nitrofurantoin—Body temperature increased—Fluorouracil—skin cancer	0.000283	0.00174	CcSEcCtD
Nitrofurantoin—Asthenia—Temozolomide—skin cancer	0.000278	0.00171	CcSEcCtD
Nitrofurantoin—Cough—Docetaxel—skin cancer	0.000276	0.0017	CcSEcCtD
Nitrofurantoin—Nausea—Bleomycin—skin cancer	0.000273	0.00168	CcSEcCtD
Nitrofurantoin—Vomiting—Dactinomycin—skin cancer	0.000273	0.00168	CcSEcCtD
Nitrofurantoin—Rash—Dactinomycin—skin cancer	0.000271	0.00166	CcSEcCtD
Nitrofurantoin—Myalgia—Docetaxel—skin cancer	0.000269	0.00165	CcSEcCtD
Nitrofurantoin—Chest pain—Docetaxel—skin cancer	0.000269	0.00165	CcSEcCtD
Nitrofurantoin—Diarrhoea—Temozolomide—skin cancer	0.000266	0.00163	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Fluorouracil—skin cancer	0.000263	0.00162	CcSEcCtD
Nitrofurantoin—Confusional state—Docetaxel—skin cancer	0.00026	0.0016	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Docetaxel—skin cancer	0.000258	0.00159	CcSEcCtD
Nitrofurantoin—Dizziness—Temozolomide—skin cancer	0.000257	0.00158	CcSEcCtD
Nitrofurantoin—Nausea—Dactinomycin—skin cancer	0.000255	0.00157	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Docetaxel—skin cancer	0.000253	0.00155	CcSEcCtD
Nitrofurantoin—Vomiting—Temozolomide—skin cancer	0.000247	0.00152	CcSEcCtD
Nitrofurantoin—Anorexia—Docetaxel—skin cancer	0.000246	0.00151	CcSEcCtD
Nitrofurantoin—Rash—Temozolomide—skin cancer	0.000245	0.0015	CcSEcCtD
Nitrofurantoin—Diarrhoea—Fluorouracil—skin cancer	0.000245	0.0015	CcSEcCtD
Nitrofurantoin—Headache—Temozolomide—skin cancer	0.000243	0.00149	CcSEcCtD
Nitrofurantoin—Dizziness—Fluorouracil—skin cancer	0.000236	0.00145	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000235	0.00145	CcSEcCtD
Nitrofurantoin—Paraesthesia—Docetaxel—skin cancer	0.000232	0.00142	CcSEcCtD
Nitrofurantoin—Nausea—Temozolomide—skin cancer	0.000231	0.00142	CcSEcCtD
Nitrofurantoin—Dyspnoea—Docetaxel—skin cancer	0.00023	0.00141	CcSEcCtD
Nitrofurantoin—Somnolence—Docetaxel—skin cancer	0.000229	0.00141	CcSEcCtD
Nitrofurantoin—Vomiting—Fluorouracil—skin cancer	0.000227	0.0014	CcSEcCtD
Nitrofurantoin—Dyspepsia—Docetaxel—skin cancer	0.000227	0.0014	CcSEcCtD
Nitrofurantoin—Rash—Fluorouracil—skin cancer	0.000225	0.00139	CcSEcCtD
Nitrofurantoin—Decreased appetite—Docetaxel—skin cancer	0.000224	0.00138	CcSEcCtD
Nitrofurantoin—Headache—Fluorouracil—skin cancer	0.000224	0.00138	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000223	0.00137	CcSEcCtD
Nitrofurantoin—Constipation—Docetaxel—skin cancer	0.000221	0.00136	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Docetaxel—skin cancer	0.000213	0.00131	CcSEcCtD
Nitrofurantoin—Nausea—Fluorouracil—skin cancer	0.000212	0.00131	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Docetaxel—skin cancer	0.000211	0.0013	CcSEcCtD
Nitrofurantoin—Abdominal pain—Docetaxel—skin cancer	0.000204	0.00125	CcSEcCtD
Nitrofurantoin—Body temperature increased—Docetaxel—skin cancer	0.000204	0.00125	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Docetaxel—skin cancer	0.00019	0.00117	CcSEcCtD
Nitrofurantoin—Asthenia—Docetaxel—skin cancer	0.000185	0.00114	CcSEcCtD
Nitrofurantoin—Diarrhoea—Docetaxel—skin cancer	0.000177	0.00109	CcSEcCtD
Nitrofurantoin—Dizziness—Docetaxel—skin cancer	0.000171	0.00105	CcSEcCtD
Nitrofurantoin—Vomiting—Docetaxel—skin cancer	0.000164	0.00101	CcSEcCtD
Nitrofurantoin—Rash—Docetaxel—skin cancer	0.000163	0.001	CcSEcCtD
Nitrofurantoin—Headache—Docetaxel—skin cancer	0.000162	0.000994	CcSEcCtD
Nitrofurantoin—Nausea—Docetaxel—skin cancer	0.000153	0.000942	CcSEcCtD
